Bicycle Therapeutics plc - ADR (BCYC)

Profile

https://www.bicycletherapeutics.com

Bicycle Therapeutics plc - ADR is a clinical-stage biopharmaceutical company focused on developing a novel class of medicines known as Bicycle molecules. The company applies its proprietary bicyclic peptide platform to create targeted therapies designed to address diseases that are underserved by existing treatments, with a primary emphasis on oncology and other serious conditions. Its current pipeline includes Bicycle toxin conjugates and related precision medicine programs that are being evaluated in clinical trials for tumor types and other disease areas. Bicycle Therapeutics also works with partners to extend its technology into additional therapeutic applications, including radiopharmaceutical and non-oncology research. Based in Cambridge, United Kingdom, Bicycle Therapeutics plc - ADR plays a specialized role in the biotechnology market by advancing highly selective drug candidates that combine small-molecule-like properties with peptide-based targeting.